SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-043016
Filing Date
2023-07-20
Accepted
2023-07-20 21:52:40
Documents
2
Period of Report
2023-07-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2962
2 POA DOCUMENT poa.txt EX-24 3981
  Complete submission text file 0001209191-23-043016.txt   8361
Mailing Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010
Business Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010 347-897-5988
Turnstone Biologics Corp. (Issuer) CIK: 0001764974 (see all company filings)

IRS No.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SENTI BIOSCIENCES, INC. 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Rajangam Kanya (Reporting) CIK: 0001816676 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41747 | Film No.: 231100986